A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors

Clinical trial NCT07524348 · RECRUITING

Trial details

NCT number: NCT07524348
Sponsor: Samsung Bioepis Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2026-03-23
Primary completion: 2030-07-01
Enrollment: 149

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.